Lower doses to hippocampi and other brain structures for skull-base meningiomas with IMPT compared to photon therapy.
07/09/2019
/
Publications
/
IMPT
VMAT
This study systematically compared intensity modulated proton therapy (IMPT), non-coplanar volumetric modulated arc therapy (VMAT) and intensity modulated...
The first prototype of spot-scanning proton arc treatment delivery.
03/05/2019
/
Publications
/
ARC therapy
IMPT
Published in the Green Journal, the Beaumont group reported the first prototype of spot-scanning arc treatment (SPArc) delivery on IBA Proteus®One. The brain...
Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.
10/10/2020
/
Publications
/
Toxicity
IMPT
This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...
Proton Therapy in NSCLC
11/11/2018
/
Publications
/
IMPT
Immunotherapy
A review on PBT for NSCLC. The review pointed out that despite early results suggesting improvements or at least comparable outcomes, the most recent randomized...
IMPT decreases dose to organs at risk in low-grade glioma patients
11/11/2018
/
Publications
/
IMRT
VMAT
IMPT
Patients with low-grade glioma (LGG) have a prolonged survival expectancy, therefore long-term side effects caused by radiotherapy is a concern. This...
Patterns of Local-Regional Failure after IMRT or Passive Scattering PT with Concurrent Chemotherapy for NSCLC.
08/08/2018
/
Publications
/
IMPT
Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 212 patients treated with IMRT and PT, most (152 [72%]) had no failure...
Advanced radiation techniques for locally advanced NSCLC: IMRT and proton therapy.
08/08/2018
/
Publications
/
IMPT
IMRT
This review article examined clinical outcomes data of IMRT and PBT for locally advanced NSCLC. This review pointed out that PBT is not considered the standard...
Reirradiation for locoregionally recurrent non-small cell lung cancer.
08/08/2018
/
Publications
/
Reirradiation
IMPT
Survival
In the context of definitive retreatment, increasing reRT dose can potentially improve OS and offer a chance of cure, particularly in patients with limited loco...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
11/06/2017
/
Publications
/
IMPT
Chemotherapy
Toxicity
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
15/11/2022
/
Publications
/
IMPT
IMRT
Published in the Green Journal, the PTCOG lymphoma subcommittee conducted a systematic review on available dosimetric studies comparing IMPT free breathing (FB)...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.